Pharmacokinetic and Pharmacodynamic Analysis of the 3CL Protease Inhibitor Ensitrelvir in a SARS-CoV-2 Infection Mouse Model

por Fukao, Keita, Nobori, Haruaki, Kuroda, Takayuki, Baba, Kaoru, Matsumoto, Kazumi, Tanaka, Yukari, Tachibana, Yuki, Kato, Teruhisa, Shishido, Takao
Publicado 2023

Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection

por Fukao, Keita, Noshi, Takeshi, Yamamoto, Atsuko, Kitano, Mitsutaka, Ando, Yoshinori, Noda, Takahiro, Baba, Kaoru, Matsumoto, Kazumi, Higuchi, Naoko, Ikeda, Minoru, Shishido, Takao, Naito, Akira
Publicado 2019

Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo

por Kuroda, Takayuki, Nobori, Haruaki, Fukao, Keita, Baba, Kaoru, Matsumoto, Kazumi, Yoshida, Shinpei, Tanaka, Yukari, Watari, Ryosuke, Oka, Ryoko, Kasai, Yasuyuki, Inoue, Kae, Kawashima, Sho, Shimba, Alice, Hayasaki-Kajiwara, Yoko, Tanimura, Miki, Zhang, Qianhui, Tachibana, Yuki, Kato, Teruhisa, Shishido, Takao
Publicado 2023